27th May 2005 07:00
Medical Solutions PLC26 May 2005 Medical Solutions plc ("Medical Solutions") Medical Solutions announces agreement with AstraZeneca Medical Solutions, the provider of pathology-based products and services to thehealthcare and pharmaceuticals sector, announces that it has entered into anagreement with AstraZeneca UK Ltd ("AstraZeneca") to provide biomarker analysisin support of one of AstraZeneca's key therapeutic programmes. Medical Solutions will perform immunohistochemical staining and analysis inorder to quantify changes in the expression of key biomarkers. Expression levelswill be compared between individuals with and without administration of anunnamed therapeutic product. The project is expected to be completed by the end of July 2005 and it is worthapproximately £300,000. For further information: Medical SolutionsCharles Green/Neil Johnston 0115 973 9010 Bell PottingerGeoff Callow 020 7861 3877Chris Hamilton 020 7861 3867 Notes to Editors Medical Solutions is a provider of pathology-based products and services to thehealthcare and pharmaceutical sector with advanced technology in image analysis,virtual microscopy and quantitative biomarker determination. Its servicedivision has established ethical, fully consented tissue banks, created anetwork of over 90 specialist pathologists to provide reporting services to boththe NHS and the private sector, and has an established drug development serviceproviding quantitative tissue analysis for molecularly targeted therapeuticagents. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SBS.L